Work

FOXP3+ T-cell infiltration is associated with improved outcomes in metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICI).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.549

Authors: Elio Adib, Talal El Zarif, Dory Freeman, Muhieddine Labban, Catherine Curran, Bijaya Sharma, Jane Song, Kristen Felt, Amin Nassar, Matthew Davidsohn, Scott J. Rodig, Toni K. Choueiri, David J. Kwiatkowski, Praful Ravi, Guru P. Sonpavde

Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Harvard University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4212795478

Cites:

Cited by: 1

Related to: 10